Complex Decongestive Therapy, Cryotherapy and Kinesio Taping in Patients With Post-mastectomy Lymphedema
Overview
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- South Valley University
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Pain severity is measured by VAS
Overview
Brief Summary
To examine the efficacy of complex decongestive therapy (CDT), cryotherapy and kinesio taping (KT) in patients with post-mastectomy lymphedema
Detailed Description
Sixty women diagnosed clinically by physician as post-mastectomy lymphedema, suffered from grade 2 and 3 lymphedema based on clinical investigations and their ages between 40 and 60 years were randomly assigned in single pre - post measurement study. They divided randomly into three groups of equal size (A, B & C). The three groups received CDT program, group (A) (n=20) received CDT only, group (B) (n=20) received cryotherapy and group (C) (n=20) received KT
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Participant)
Eligibility Criteria
- Ages
- 40 Years to 60 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Patients aged between 40 to 60 years. They were grade 2 and 3 lymphedema. They had more than 2 cm difference at circumference measurement. They had unilateral arm lymphedema post-mastectomy. They had completed chemotherapy and radiotherapy.
Exclusion Criteria
- •Skin infection. Current ischemia. Systemic edema due to impaired heart, kidney and liver function. Current metastases. Venous thrombosis.
Outcomes
Primary Outcomes
Pain severity is measured by VAS
Time Frame: 12 consecutive weeks
It consisted of a line, often 10 cm long (100 mm); its ends are generally labelled with verbal pain anchors (e.g., "no pain" and "pain as bad as it could be")
Arm girth measurement is measured by Circumferential measurements
Time Frame: 12 consecutive weeks
It is a valid and reliable method, its protocol was used throughout, with measures performed on both arms at the axilla, halfway from the axilla to the cubital fossa, cubital fossa, halfway from the cubital fossa to the wrist, and at the wrist.
Secondary Outcomes
- Range of motion (ROM) is measured by UG(12 consecutive weeks)
- The QOL is measured by SF-36(12 consecutive weeks)
Investigators
Ragaee Saeed Mahmoud
Lecturer
National Cancer Institute (NCI)